These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis. Mooradian MJ; Wang DY; Coromilas A; Lumish M; Chen T; Giobbie-Hurder A; Johnson DB; Sullivan RJ; Dougan M J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414860 [TBL] [Abstract][Full Text] [Related]
3. Microscopic colitis: a therapeutic challenge. Guslandi M World J Gastroenterol; 2013 Jun; 19(23):3531-3. PubMed ID: 23801853 [TBL] [Abstract][Full Text] [Related]
4. Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients. Daferera N; Hjortswang H; Ignatova S; Münch A United European Gastroenterol J; 2019 Nov; 7(9):1234-1240. PubMed ID: 31700636 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1). Fellermann K; Schiefke I; Rácz I; Derova J; Jonaitis L; Wehrum S; Nacak T; Greinwald R United European Gastroenterol J; 2020 Dec; 8(10):1186-1195. PubMed ID: 33028169 [TBL] [Abstract][Full Text] [Related]
6. Use of budesonide in the treatment of microscopic colitis. Tangri V; Chande N Saudi J Gastroenterol; 2010; 16(3):236-8. PubMed ID: 20616427 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with long-term clinical outcome in microscopic colitis. Miyatani Y; Komaki Y; Komaki F; Micic D; Keyashian K; Sakuraba A Ann Med; 2024 Dec; 56(1):2365989. PubMed ID: 38900021 [TBL] [Abstract][Full Text] [Related]
8. Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial. Münch A; Mihaly E; Nagy F; Madisch A; Kupčinskas J; Miehlke S; Bohr J; Bouma G; Guardiola J; Belloc B; Shi C; Aust D; Mohrbacher R; Greinwald R; Munck LK United European Gastroenterol J; 2021 Sep; 9(7):837-847. PubMed ID: 34414678 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of microscopic colitis. Tysk C; Bohr J; Nyhlin N; Wickbom A; Eriksson S World J Gastroenterol; 2008 Dec; 14(48):7280-8. PubMed ID: 19109861 [TBL] [Abstract][Full Text] [Related]
10. American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis. Nguyen GC; Smalley WE; Vege SS; Carrasco-Labra A; Gastroenterology; 2016 Jan; 150(1):242-6; quiz e17-8. PubMed ID: 26584605 [No Abstract] [Full Text] [Related]
11. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics, and response to treatment in 113 patients with microscopic colitis. Rojo E; Casanova MJ; P Gisbert J Gastroenterol Hepatol; 2021 Dec; 44(10):671-679. PubMed ID: 33248178 [TBL] [Abstract][Full Text] [Related]
13. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis. Enwerem NY; Yen EF Curr Opin Gastroenterol; 2024 Jan; 40(1):50-59. PubMed ID: 37874119 [TBL] [Abstract][Full Text] [Related]
14. Contemporary methods for the diagnosis and treatment of microscopic colitis. Jauregui-Amezaga A; Vermeire S; Geboes K Expert Rev Gastroenterol Hepatol; 2016; 10(1):47-61. PubMed ID: 26470823 [TBL] [Abstract][Full Text] [Related]
15. Oral budesonide for induction of remission in ulcerative colitis. Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719 [TBL] [Abstract][Full Text] [Related]
16. Microscopic Colitis: A Rare Cause of Pseudomembranes. Schenck RJ; Cohen GS; Pezhouh MK Clin Gastroenterol Hepatol; 2019 Aug; 17(9):e101. PubMed ID: 29981436 [No Abstract] [Full Text] [Related]
17. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Gentile NM; Abdalla AA; Khanna S; Smyrk TC; Tremaine WJ; Faubion WA; Kammer PP; Sandborn WJ; Loftus EV; Pardi DS Am J Gastroenterol; 2013 Feb; 108(2):256-9. PubMed ID: 23295275 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study. Kamboj AK; McGoldrick J; Voth E; Penrice D; Tome J; Gujral A; Miller K; Burke KE; Pardi DS; Khalili H Dig Dis Sci; 2022 Jul; 67(7):3108-3114. PubMed ID: 34283360 [TBL] [Abstract][Full Text] [Related]
19. New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation. Tariq R; Smyrk T; Pardi DS; Tremaine WJ; Khanna S Am J Gastroenterol; 2016 May; 111(5):751-2. PubMed ID: 27151129 [No Abstract] [Full Text] [Related]
20. Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives. Dougan M Curr Gastroenterol Rep; 2020 Mar; 22(4):15. PubMed ID: 32185493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]